TAK-279 Clinical Trials (2026): 12 Studies for Healthy Volunteers & Plaque Psoriasis
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
12 TAK-279 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 7 indications (including Healthy Volunteers & Plaque Psoriasis) and 4,780 total planned enrollment. 4 Phase 3 TAK-279 trials and 2 Phase 2 are listed. 1 TAK-279 clinical trial is actively recruiting at 23 U.S. sites across 14 states. Most recent activity: NCT06550076 (Aug 2029).
Where to Participate: All TAK-279 Trial Sites in the U.S. (23 sites across 14 states)
Every actively recruiting TAK-279trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | United Medical Doctors | Murrieta92563 | NCT06233461 | Map |
| CA | UCI Health | Orange92868 | NCT06233461 | Map |
| FL | West Central Gastroenterology, LLP, d/b/a/ Gastro Florida | Clearwater33762 | NCT06233461 | Map |
| FL | Auzmer Research | Lakeland33813 | NCT06233461 | Map |
| FL | Wellness Clinical Research | Miami Lakes33016 | NCT06233461 | Map |
| FL | GI PROS, Inc. | Naples34102 | NCT06233461 | Map |
| FL | USF Health Morsani Center for Advanced Healthcare | Tampa33612 | NCT06233461 | Map |
| GA | Emory University Hospital, The Emory Clinic | Atlanta30322 | NCT06233461 | Map |
| GA | Atlanta Center For Gastroenterology, P.C. | Decatur30033 | NCT06233461 | Map |
| IA | The University of Iowa Hospitals & Clinics | Iowa City52242 | NCT06233461 | Map |
| KY | University Of Louisville | Louisville40202 | NCT06233461 | Map |
| MD | Woodholme Gastroenterology Associates | Glen Burnie21061 | NCT06233461 | Map |
| MO | BVL Clinical Research | Liberty64068 | NCT06233461 | Map |
| NV | Las Vegas Medical Research | Las Vegas89128 | NCT06233461 | Map |
| NY | Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) | New York10029 | NCT06233461 | Map |
| NY | Rochester Clinical Research | Rochester14609 | NCT06233461 | Map |
| OH | Great Lakes Gastroenterology Research, LLC | Mentor44060 | NCT06233461 | Map |
| RI | University Gastroenterology Providence | Providence02904 | NCT06233461 | Map |
| SC | Gastroenterology Associates, PA | Greenville29615 | NCT06233461 | Map |
| TX | Novel Research, LLC | Bellaire77401 | NCT06233461 | Map |
| TX | Southern Star Research Institute, LLC | San Antonio78229 | NCT06233461 | Map |
| TX | Tyler Research Institute, LLC | Tyler75701 | NCT06233461 | Map |
| WA | University of Washington Medical Center | Seattle98195 | NCT06233461 | Map |
TAK-279 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | Total |
|---|---|---|---|---|
| P1 | 6 | 6 | ||
| P2 | 1 | 1 | 2 | |
| P3 | 2 | 2 | 4 |
Recruiting TAK-279 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT06233461 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease | P2 | Crohn's Disease | 268 | Mar 2024 |
TAK-279 clinical trials by indication
Healthy Volunteers (4)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06111547 | — | P1 | completed | A Study of TAK-279 in Healthy Chinese Adults |
| NCT06258265 | — | P1 | completed | A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements |
| NCT06290050 | — | P1 | completed | A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults |
| NCT05995249 | — | P1 | completed | A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults |
Plaque Psoriasis (3)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06550076 | — | P3 | active not recruiting | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis |
| NCT06108544 | — | P3 | completed | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period |
| NCT06088043 | — | P3 | completed | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment |
Ulcerative Colitis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06254950 | — | P2 | active not recruiting | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis |
Generalized Pustular Psoriasis (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06323356 | — | P3 | active not recruiting | A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis |
Crohn's Disease (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06233461 | — | P2 | recruiting | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease |
Renal Impairment (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05992155 | — | P1 | completed | A Study of TAK-279 in Adults With or Without Kidney Problems |
Hepatic Impairment (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05976321 | — | P1 | completed | A Study of TAK-279 in Adults With or Without Liver Damage |
All TAK-279 trials (12)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06550076 | A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis | P3 | active not recruiting | 2,099 | Takeda | Sep 2024 | |
| NCT06254950 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis | P2 | active not recruiting | 207 | Takeda | Mar 2024 | |
| NCT06233461 | A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease | P2 | recruiting | 268 | Takeda | Mar 2024 | |
| NCT06323356 | A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis | P3 | active not recruiting | 18 | Takeda | Mar 2024 | |
| NCT06108544 | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period | P3 | completed | 1,108 | Takeda | Nov 2023 | |
| NCT06088043 | A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment | P3 | completed | 693 | Takeda | Nov 2023 | |
| NCT06111547 | A Study of TAK-279 in Healthy Chinese Adults | P1 | completed | 24 | Takeda | Jun 2024 | |
| NCT06258265 | A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements | P1 | completed | 120 | Takeda | Apr 2024 | |
| NCT05992155 | A Study of TAK-279 in Adults With or Without Kidney Problems | P1 | completed | 24 | Takeda | Sep 2023 | |
| NCT06290050 | A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults | P1 | completed | 20 | Takeda | Mar 2024 | |
| NCT05976321 | A Study of TAK-279 in Adults With or Without Liver Damage | P1 | completed | 27 | Takeda | Sep 2023 | |
| NCT05995249 | A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults | P1 | completed | 172 | Takeda | Aug 2023 |
TAK-279 clinical trials: frequently asked questions
- How many TAK-279 clinical trials are there?
- 12 TAK-279 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 8 are marked completed.
- Are TAK-279 clinical trials recruiting in 2026?
- Yes — 1 TAK-279 trial is actively recruiting in 2026, with 23 U.S. sites across 14 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is TAK-279 being studied for?
- TAK-279 is being studied for Healthy Volunteers, Plaque Psoriasis, Generalized Pustular Psoriasis, Hepatic Impairment, Renal Impairment and 3 more. The trials are grouped by indication on this page.
- What phase is TAK-279 in?
- TAK-279 clinical trials span 4 Phase 3, 2 Phase 2, 6 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors TAK-279 clinical trials?
- The lead sponsor across the most TAK-279 trials is Takeda. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming TAK-279as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: